These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23413976)

  • 41. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
    Wan M; Smith C; Shah V; Gullet A; Wells D; Rees L; Shroff R
    Nephrol Dial Transplant; 2013 Jan; 28(1):153-61. PubMed ID: 23180879
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fibroblast growth factor 23 in feline chronic kidney disease.
    Geddes RF; Finch NC; Elliott J; Syme HM
    J Vet Intern Med; 2013; 27(2):234-41. PubMed ID: 23398216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fibroblast growth factor 23 and calcium phosphate homeostasis after pediatric renal transplantation.
    van Husen M; Lehnhardt A; Fischer AK; Brinkert F; Loos S; Oh J; Kemper MJ
    Pediatr Transplant; 2012 Aug; 16(5):443-50. PubMed ID: 22554017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Responsiveness of FGF-23 and mineral metabolism to altered dietary phosphate intake in chronic kidney disease (CKD): results of a randomized trial.
    Sigrist M; Tang M; Beaulieu M; Espino-Hernandez G; Er L; Djurdjev O; Levin A
    Nephrol Dial Transplant; 2013 Jan; 28(1):161-9. PubMed ID: 23024219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FGF-23 in children with CKD: a new player in the development of CKD-mineral and bone disorder.
    Siomou E; Stefanidis CJ
    Nephrol Dial Transplant; 2012 Dec; 27(12):4259-62. PubMed ID: 22848110
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis.
    Seeherunvong W; Abitbol CL; Chandar J; Rusconi P; Zilleruelo GE; Freundlich M
    Pediatr Nephrol; 2012 Nov; 27(11):2129-2136. PubMed ID: 22710695
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FGF-23 levels are associated with vascular calcification, but not with atherosclerosis, in hemodialysis patients.
    Turan MN; Kircelli F; Yaprak M; Sisman AR; Gungor O; Bayraktaroglu S; Ozkahya M; Asci G; Floege J; Ok E
    Int Urol Nephrol; 2016 Apr; 48(4):609-17. PubMed ID: 26865177
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [MORPHOGENETIC PROTEINS--FIBROBLAST GROWTH FACTOR AND KLOTHO, IN THE SERA OF PATIENTS WITH CHRONIC RENAL DISEASE].
    Milovanova LY; Kozlovskaya LV; Markina MM; Milovanova SY; Borisov AA; Mukhin NA; Fomin VV; Moiseev SV
    Klin Med (Mosk); 2015; 93(12):32-8. PubMed ID: 27149811
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between cFGF23/Klotho ratio and phosphate levels in patients with chronic kidney disease.
    Liu Z; Zhou H; Chen X; Chen H; Wang Y; Wang T; Cai L; Hong Y; Ke H; Zheng J
    Int Urol Nephrol; 2019 Mar; 51(3):503-507. PubMed ID: 30689182
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis.
    Wesseling-Perry K; Pereira RC; Wang H; Elashoff RM; Sahney S; Gales B; Jüppner H; Salusky IB
    J Clin Endocrinol Metab; 2009 Feb; 94(2):511-7. PubMed ID: 19050056
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients.
    Tomida K; Hamano T; Mikami S; Fujii N; Okada N; Matsui I; Nagasawa Y; Moriyama T; Ito T; Imai E; Isaka Y; Rakugi H
    Bone; 2009 Apr; 44(4):678-83. PubMed ID: 19111635
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.
    Larsson T; Nisbeth U; Ljunggren O; Jüppner H; Jonsson KB
    Kidney Int; 2003 Dec; 64(6):2272-9. PubMed ID: 14633152
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum fibroblast growth factor 23 (FGF-23): associations with hyperphosphatemia and clinical staging of feline chronic kidney disease.
    Lin J; Lin L; Chen S; Yu L; Chen S; Xia Z
    J Vet Diagn Invest; 2021 Mar; 33(2):288-293. PubMed ID: 33543676
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum levels of fibroblast growth factor-21 are increased in chronic and acute renal dysfunction.
    Hindricks J; Ebert T; Bachmann A; Kralisch S; Lössner U; Kratzsch J; Stolzenburg JU; Dietel A; Beige J; Anders M; Bast I; Blüher M; Stumvoll M; Fasshauer M
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):918-24. PubMed ID: 24612017
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Association of Fibroblast Growth Factor 23 with Arterial Stiffness and Atherosclerosis in Patients with Autosomal Dominant Polycystic Kidney Disease.
    Coban M; Inci A; Yılmaz U; Asilturk E
    Kidney Blood Press Res; 2018; 43(4):1160-1173. PubMed ID: 30064143
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.
    Sánchez Fructuoso AI; Maestro ML; Pérez-Flores I; Valero R; Rafael S; Veganzones S; Calvo N; De la Orden V; De la Flor JC; Valga F; Vidaurreta M; Fernández-Pérez C; Barrientos A
    Nephrol Dial Transplant; 2012 Nov; 27(11):4227-35. PubMed ID: 23144073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of interactions between proteinuria, activity of fibroblast growth factor 23 and serum phosphate on renal progression in patients with chronic kidney disease: a result from the KoreaN cohort study for Outcome in patients With Chronic Kidney Disease study.
    Kim H; Park J; Nam KH; Jhee JH; Yun HR; Park JT; Han SH; Chung W; Oh KH; Park SK; Kim SW; Kang SW; Choi KH; Ahn C; Yoo TH
    Nephrol Dial Transplant; 2020 Mar; 35(3):438-446. PubMed ID: 30615179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis.
    Kojima F; Uchida K; Ogawa T; Tanaka Y; Nitta K
    Int Urol Nephrol; 2008; 40(4):1067-74. PubMed ID: 18791804
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fibroblast growth factor is associated to left ventricular mass index, anemia and low values of transferrin saturation.
    Eser B; Yayar O; Buyukbakkal M; Erdogan B; Ercan Z; Merhametsiz O; Haspulat A; Oğuz EG; Dogan İ; Canbakan B; Ayli MD
    Nefrologia; 2015; 35(5):465-72. PubMed ID: 26394828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.